Anti-FcRn antibodies

Abstract The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA. 13423654_1 (GHMatters) P98231.AU.2 r

Saved in:
Bibliographic Details
Main Authors SARKAR, Kaushik, ATHERFOLD, Paul Alan, FINNEY, Helene Margaret, TYSON, Kerry Louise, MEIER, Christoph, LAWSON, Alastair David Griffiths, KEVORKIAN, Lara, SMITH, Bryan John, SHAW, Stevan Graham
Format Patent
LanguageEnglish
Published 03.09.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract The disclosure relates to antibodies specific to FcRn, formulations comprising the same, use of each in therapy, processes for expressing and optionally formulating said antibody, DNA encoding the antibodies and hosts comprising said DNA. 13423654_1 (GHMatters) P98231.AU.2 r
Bibliography:Application Number: AU20200217370